Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn more about both HIV-1 infection and advancing age, and their association with increased risk of serious infection and impaired response to the Prevnar 13 vaccine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
VA Eastern Colorado Health Care System
NCT07466836 · Human Immunodeficiency Virus (HIV)
NCT06749054 · HIV-1-infection
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT07115901 · HIV (Human Immunodeficiency Virus)
Rocky Mountain Regional VA Medical Center
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions